- Country profiles
- Data dashboard
- Satellite Pages
- About us
- WHAT'S NEW
Providing evidence-based guidelines to inform public health service delivery for Member States and other stakeholders is one of the core responsibilities of the World Health Organization (WHO). To support countries in responding to the challenges of TB and drug-resistant TB, the WHO Global TB Programme regularly issues evidence-based guidelines using the international GRADE4 (Grading of Recommendations, Assessment, Development and Evaluation) approach for scientific evidence assessment.
The costing guidelines explain how to cost TB interventions from the perspective of the providers of health services. The provider perspective takes the point of view of the provision of services; the costs are those incurred by a hospital, clinic or TB facility providing the services. Tools for data collection referred to as the Value TB Costing Tool Suite are included.
Concerted and integrated efforts are needed to prevent and address both TB and TB-HIV burden in the region.
2 out of 3 TB infections globally are in Asia and the Pacific and 60% of MDR-TB burden is in this region. Globally, Asia and the Pacific is the home for 13% of PLHIV but 20% of TB-HIV co-infections are in this region. Systematic collaboration between TB-HIV programmes will save lives and improve the quality of life of people living with and affected by HIV and TB.
The Compendium has been developed as a clear and concise instrument to facilitate the understanding and planning of delivery of high-quality care for everybody affected by TB. It incorporates all recent policy guidance from WHO; follows the care pathway of persons with signs or symptoms of TB in seeking diagnosis, treatment and care; and includes key algorithms and cross-cutting elements that are essential to a patient-centered approach in the cascade of TB care.
The WHO South-East Asia (SEA) Region has some of the highest TB-burden countries, and nearly half of all TB cases in the world are to be found in people from this Region. The Region has nearly half the global burden in terms of new cases (incidence), and close to 40% of the burden in terms of deaths due to TB. And this while only 26% of the global population lives in the Region.
Keywords: TB, drug-resistant, treatment, funding
WHO has published a global TB report every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease at global, regional and country levels. This is done in the context of recommended global TB strategies and targets endorsed by WHO’s Member States and broader development goals set by the United Nations.
Keywords: TB, prevention, diagnosis, treatment, drug-resistant
HIV-associated TB presents a risk to achieving the Sustainable Development Goals. Effective, sustained action is required to meet the needs of the most vulnerable populations.
Keywords: TB, PLHIV, treatment, diagnostic, deaths
The 2018 United Nations General Assembly High-Level Meeting (HLM) on Tuberculosis and the current revision of the Roadmap for childhood tuberculosis together present an important moment to consolidate and advance advocacy, commitment, resource mobilization and joint efforts by all stakeholders to provide health care and address the burden of TB among children
Keywords: TB, HIV, multidrug-resistant, treatment, advocacy
Community voices and leadership in governance, implementation and oversight of Global Fund-supported programs is essential to achieving lasting impact.
Lessons from the Ebola response and the transition to the Sustainable Development Goals, with the specific target of achieving universal health coverage, have spurred the Global Fund to reflect on how people access health services and how countries respond to health crises. Rethinking our approaches to building resilient and sustainable systems for health will be essential in order to maximize equitable access and impact on HIV, TB and malaria.
This document captures the achievements from 2015-2017 of the Multi-Country Western Pacific Integrated HIV/TB Programme. The programme improved the coverage and quality of HIV/TB prevention, treatment and care in 11 countries: Cook Islands, Federated States of Micronesia, Kiribati, Marshall Islands, Nauru, Niue, Palau, Samoa, Tonga, Tuvalu and Vanuatu.